ONCO - Onconetix, Inc.
0.6664
-0.061 -9.199%
Share volume: 1,143,088
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.73
-0.06
-0.08%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 06-12-2025 | 11-13-2025 | 03-13-2026 | |
| Cash flow financing | 2.870 M | 4.291 M | 6.547 M | |
| Other financing cash flows | 0.000 | 926.000 | -926.000 | |
| Cash flow | 870.574 K | 0.000 | 0.000 | |
| Net income | -8.546 M | -8.784 M | 5.670 M | |
| Depreciation | 4.748 K | 3.387 K | 3.336 K | |
| Changes in inventories | 91.019 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | 930.693 K | 1.286 M | 3.084 M |